188.56
+3.18
+(1.72%)
At close: January 15 at 5:32:06 PM GMT+1
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 40 | 29 | 53 | 53 |
Avg. Estimate | 96.66B | 89.87B | 350.1B | 390.77B |
Low Estimate | 94.87B | 87.48B | 347.36B | 380.1B |
High Estimate | 98.9B | 91.63B | 353B | 399.53B |
Year Ago Sales | 86.31B | 80.54B | 307.39B | 350.1B |
Sales Growth (year/est) | 11.99% | 11.59% | 13.89% | 11.62% |
EPS Trend
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
GOOA.VI | -- | -- | -- | -- |
S&P 500 | 8.43% | 11.29% | 13.87% | 13.50% |
Upgrades & Downgrades
Maintains | Morgan Stanley: Overweight to Overweight | 1/13/2025 |
Maintains | Stifel: Buy to Buy | 1/13/2025 |
Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 1/13/2025 |
Reiterates | JMP Securities: Market Perform to Market Perform | 1/10/2025 |
Maintains | Keybanc: Overweight to Overweight | 1/10/2025 |
Maintains | Wedbush: Outperform to Outperform | 1/6/2025 |